Source: Virtual Congress 2020 – The impact of different treatment modalities on obstructive sleep apnoea
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
J. Kelly (London, United Kingdom), A. Wimms (Sydney, Australia), C. Turnbull (Oxford, United Kingdom), A. Mcmillan (Stevenage, United Kingdom), S. Craig (Liverpool, United Kingdom), J. O'Reilly (Liverpool, United Kingdom), A. Nickol (Oxford, United Kingdom), E. Hedley (Oxford, United Kingdom), M. Decker (Encinita, United States of America), L. Willes (Encinita, United States of America), P. Calverley (Liverpool, United Kingdom), A. Benjafield (Sydney, Australia), J. Stradling (Oxford, United Kingdom), M. Morrell (London, United Kingdom). The effect of CPAP on quality of life in patients with ‘very’ mild Obstructive Sleep Apnoea (OSA): Results from a subset of the MERGE Randomised Trial. 4736

Member's Comments

No comment yet.

Related content which might interest you: Obstructive sleep apnea (OSA) in elderly patients. Role of continuos positive airway pressure (CPAP) treatment. A multicenter randomized controlled clinical trial Source: International Congress 2014 – Three ages of man: OSA in children, adults and the elderly Year: 2014 Late Breaking Abstract - Effectiveness of multimodal remote patient monitoring at CPAP initiation in Obstructive Sleep Apnea (OSA) with high cardiovascular risk: A randomized trial Source: International Congress 2017 – Risk factors: symptomatology and diagnostic approaches for obstructive sleep apnoea Year: 2017 The effects of short-term CPAP withdrawal on myocardial perfusion in OSA – A randomised placebo-controlled trial Source: International Congress 2014 – Real or not? The impact of OSA and CPAP on comorbid conditions Year: 2014 Performance of utility instruments in evaluating response to CPAP in patients with obstructive sleep apnea Source: International Congress 2014 – The technical and diagnostic agenda in OSA Year: 2014 Randomized short–term trial of high span versus low span APAP for the treatment of obstructive sleep apnea Source: Annual Congress 2013 –Twist in the tale: treating sleep disordered breathing - new technologies, new techniques Year: 2013 OSAS treatment with CPAP: Randomized crossover study comparing tolerance and efficacy with and without humidification Source: International Congress 2016 – Technical aspects, compliance, and adherence to positive airway pressure in sleep apnoea Year: 2016 LATE-BREAKING ABSTRACT: The Sleep Apnea cardioVascular Endpoints (SAVE) study results – A trial of CPAP versus usual care in 2717 high cardiovascular risk patients with moderate-severe obstructive sleep apnea (OSA) Source: International Congress 2016 – Cardiovascular and metabolic pathophysiology and outcomes of obstructive sleep apnoea Year: 2016 Obstructive Sleep Apnea (OSAS) in a clinical cohort of children. Atlantis Study Source: International Congress 2017 – What is new in respiratory and sleep physiology? Year: 2017 Response to statin therapy in obstructive sleep apnea (OSA): A randomized controlled trial Source: Annual Congress 2013 –Burn after reading: inflammation in sleep disordered breathing Year: 2013 OSA results in nocturnal cerebral hypoxia which is prevented by CPAP - Data from a randomised controlled trial Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing Year: 2015 Positional therapy as a treatment for central sleep apnoea: A prospective multicentre trial Source: International Congress 2016 – Non-CPAP in obstructive and central sleep apnoea and obesity hypoventilation syndrome Year: 2016 Obstructive Sleep Apnea (OSA) Assessment in the elderly. Preliminary results. Source: International Congress 2018 – Respiratory epidemiology:  from infectious diseases to lung cancer Year: 2018 The sleepy phenotype in mild Obstructive  Sleep Apnoea (OSA) patients: from clinical characteristics to cardiometabolic risk. Data from the European Sleep Apnea Database (ESADA). Source: Virtual Congress 2021 – From phenotyping to different diagnostic tools for sleep breathing disorders Year: 2021 Nasal steroids in snorers can decrease snoring frequency – A randomized placebo-controlled crossover trial Source: International Congress 2014 – Sleep disordered breathing: from children to the elderly Year: 2014 Telemedicine in Obstructive Sleep Apnea (OSA) patients with limited internet knowledge to control their CPAP: CLIC-CPAP. Justification, design and methodology Source: International Congress 2017 – Efficacy of and compliance with obstructive sleep apnoea treatment Year: 2017 A randomized controlled study to examine the effect of lifestyle modification program in obstructive sleep apnea Source: International Congress 2015 – To treat or not to treat, and how? Sleep-disordered breathing I Year: 2015 The effect of CPAP withdrawal on blood pressure in OSA: Data from three randomised-controlled trials Source: International Congress 2014 – The story continues: impact of OSA on cardiometabolic parameters Year: 2014 Late Breaking Abstract - CPAP treatment in the very elderly with Ostructive Sleep Apnea. Pooled results from two multicenter randomized controlled trials Source: Virtual Congress 2021 – Sleep across the lifespan in the new era of COVID - 19 Year: 2021 Obstructive Sleep Apnea and use of the continuous positive airway pressure device (CPAP): patients' expectations. Source: International Congress 2017 – Medical education, web and internet Year: 2017 The prevalence of Obstructive Sleep Apnea (OSA) in patients recovering from COVID-19 Source: Sleep and Breathing Conference 2021 Year: 2021